Program
ferric carboxymaltose
Also written as “Ferric Carboxymaltose (FCM)”, “Ferric carboxymaltose” and “Injectafer”.
Its studies are mostly in Anemia, Iron-Deficiency · Anemia · Iron Deficiencies · Restless Legs Syndrome · Heart Failure, led by 4 companies.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Daiichi Sankyo | 280 open or running | phase 4since Sep 23, 2013 | Apr 20, 2006 | none ahead |
| CSL | 140 open or running | phase 4since Mar 29, 2010 | Aug 24, 2007 | none ahead |
| Sichuan Huiyu Pharmaceutical | 31 open or running | phase 1since Sep 27, 2023 | Sep 27, 2023 | none ahead |
| Novartis | 10 open or running | phase 1since Dec 5, 2017 | Dec 5, 2017 | none ahead |
Also a collaborator on its studies: Suzhou Guochen Biotechnology, Boji Medical Technology, ClinStar, Cytel, Tigermed Consulting, Pierrel Research Europe, ICON Clinical Research, Parexel and SGS.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 32 studies since Apr 20, 2006.
- Mar 27, 2015Phase 2 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT02410213 · 35 enrolled · Poland, Russian Federation
- Apr 1, 2015Phase 2 study in Iron DeficienciesDaiichi Sankyo · NCT02409459 · 81 enrolled · United States
- May 21, 2015Phase 3 study in NeoplasmsDaiichi Sankyo · NCT02453334 · 244 enrolled · United States
- Jun 30, 2016Phase 2 study in Restless Legs SyndromeDaiichi Sankyo · NCT02826681 · 70 enrolled · United States
- Oct 14, 2016Phase 4 study in Iron DeficienciesCSL · NCT02937454 · 1,132 enrolled · Argentina, Brazil, Croatia and more
- Jan 25, 2017Phase 3 study in Heart FailureDaiichi Sankyo · NCT03037931 · 3,065 enrolled · United States, Australia, Bulgaria and more
- Dec 5, 2017Novartis's first study: phase 1 study in Anemia, Iron-DeficiencyNew to NovartisNovartis · NCT03399084 · 71 enrolled · United States
- Apr 17, 2018Phase 3 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT03523117 · 79 enrolled · United States
- Jun 22, 2018Phase 3 study in Anemia, Iron-DeficiencyCSL · NCT03591406 · 371 enrolled · China
- Feb 12, 2020Phase 3 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT04269707 · 7 enrolled · United States
- Nov 2, 2020Phase 2 study in Anemia, Iron-DeficiencyDaiichi Sankyo · NCT04968379 · United States
- Sep 27, 2023Sichuan Huiyu Pharmaceutical's first study: phase 1 study in Iron DeficienciesNew to Sichuan Huiyu PharmaceuticalSichuan Huiyu Pharmaceutical · NCT06080555 · 84 enrolled · China
- Mar 20, 2025Phase 1 study in Healthy AdultSichuan Huiyu Pharmaceutical · NCT06895993 · 84 enrolled · China
- May 12, 2026Phase 1 study in Healthy AdultSichuan Huiyu Pharmaceutical · NCT07606105 · 70 planned · China
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 46 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07606105Healthy Adult · China | 1 | Recruiting | Sichuan Huiyu Pharmaceutical | Aug 26, 2026 | 70 |
| NCT06895993Healthy Adult · China | 1 | Completed | Sichuan Huiyu Pharmaceutical | May 8, 2025 | 84 |
| NCT06080555Iron Deficiencies · China | 1 | Completed | Sichuan Huiyu Pharmaceutical | Jan 22, 2024 | 84 |
| NCT04968379Anemia, Iron-Deficiency · United States | 2 | Withdrawn | Daiichi Sankyo | Oct 8, 2024 | 0 |
| NCT04269707Anemia, Iron-Deficiency · United States | 3 | Completed | Daiichi Sankyo | Dec 30, 2020 | 7 |
| NCT03591406Anemia, Iron-Deficiency · China | 3 | Completed | CSL | Feb 25, 2019 | 371 |
| NCT03523117Anemia, Iron-Deficiency · United States | 3 | Completed | Daiichi Sankyo | Dec 22, 2020 | 79 |
| NCT03399084Anemia, Iron-Deficiency · United States | 1 | Completed | Novartis | Jan 15, 2019 | 71 |
| NCT03037931Heart Failure · United States, Australia, Bulgaria and more | 3 | Completed | Daiichi Sankyo | Feb 2, 2023 | 3,065 |
| NCT02937454Iron Deficiencies · Argentina, Brazil, Croatia and more | 4 | Completed | CSL | Jul 21, 2020 | 1,132 |
| NCT02826681Restless Legs Syndrome · United States | 2 | Terminated | Daiichi Sankyo | Sep 4, 2021 | 70 |
| NCT02453334Neoplasms · United States | 3 | Completed | Daiichi Sankyo | Jan 2018 | 244 |
| NCT02409459Iron Deficiencies · United States | 2 | Completed | Daiichi Sankyo | Oct 2015 | 81 |
| NCT02410213Anemia, Iron-Deficiency · Poland, Russian Federation | 2 | Completed | Daiichi Sankyo | Jan 22, 2017 | 35 |
| NCT02397057Restless Legs Syndrome · United States | 3 | Completed | Daiichi Sankyo | Jan 2018 | 209 |
| NCT02086968Iron Deficiency Anemia Secondary to IBD or Gastric Bypass | 4 | Completed | Daiichi Sankyo | Jul 16, 2016 | 198 |
| NCT01950247Anemia, Iron-Deficiency | 4 | Completed | Daiichi Sankyo | May 20, 2015 | 1,025 |
| NCT01453608Iron Deficiencies · Poland, Russian Federation | 4 | Completed | CSL | Feb 2014 | 304 |
| NCT01394562Iron Deficiencies · Netherlands | 3 | Completed | CSL | May 2016 | 174 |
| NCT01382901Restless Legs Syndrome | 2 | Completed | Daiichi Sankyo | Jul 2007 | 45 |
| NCT01290315Anemia, Iron-Deficiency · United States | 2 | Completed | Daiichi Sankyo | Mar 2013 | 49 |
| NCT01307007Anemia, Iron-Deficiency | 2 | Completed | Daiichi Sankyo | May 2011 | 69 |
| NCT01131624Anemia · Australia, Germany, Sweden and more | 3 | Completed | CSL | May 2014 | 252 |
| NCT01110356Iron Deficiencies · Austria | 4 | Completed | CSL | Oct 2011 | 294 |
| NCT01101399Anemia, Iron-Deficiency · Germany, Sweden | 3 | Completed | CSL | Nov 2012 | 19 |
| NCT01100879Anemia, Iron-Deficiency · France, Greece | 4 | Terminated | CSL | Jul 2011 | 3 |
| NCT00994318Anemia, Iron-Deficiency · United States, Australia, Austria and more | 3 | Completed | CSL | Feb 2013 | 626 |
| NCT00982007Anemia, Iron-Deficiency · United States | 3 | Completed | Daiichi Sankyo | Mar 2011 | 997 |
| NCT00981045Anemia, Iron-Deficiency · United States | 3 | Completed | Daiichi Sankyo | Jul 2011 | 2,561 |
| NCT00882414Thrombocytosis · Austria | 2 | Terminated | CSL | Jan 2010 | 26 |
| NCT00821717Iron Deficiencies · Denmark, France, Germany and more | 3 | Terminated | CSL | Oct 2009 | 35 |
| NCT00810030Inflammatory Bowel Diseases · Austria | 3 | Completed | CSL | Dec 2009 | 484 |
| NCT00810004Iron Deficiencies · Russian Federation | 3 | Completed | CSL | Oct 2010 | 245 |
| NCT00740246Anemia · United States | 3 | Completed | Daiichi Sankyo | Feb 2006 | 594 |
| NCT00704353Anemia · United States | 3 | Completed | Daiichi Sankyo | Jul 2009 | 735 |
| NCT00704028Anemia · United States | 3 | Completed | Daiichi Sankyo | Jan 2010 | 161 |
| NCT00703937Anemia · United States | 3 | Completed | Daiichi Sankyo | Jul 2009 | 708 |
| NCT00685815Restless Legs Syndrome · United States | 2 | Completed | Daiichi Sankyo | Dec 2010 | 12 |
| NCT00548860Anemia · United States | 3 | Completed | Daiichi Sankyo | Mar 2009 | 2,018 |
| NCT00548691Anemia · United States | 3 | Completed | Daiichi Sankyo | Jan 2009 | 513 |
| NCT00520780Iron Deficiencies · Argentina, Germany, Greece and more | 3 | Completed | CSL | Jul 2009 | 456 |
| NCT00396292Anemia · United States | 3 | Completed | Daiichi Sankyo | Nov 2005 | 361 |
| NCT00395993Anemia · United States | 3 | Completed | Daiichi Sankyo | Apr 2006 | 456 |
| NCT00354484Anemia · United States | 3 | Completed | Daiichi Sankyo | Dec 2006 | 291 |
| NCT00317239Anemia · United States | 3 | Completed | Daiichi Sankyo | Feb 2007 | 255 |
| NCT00317226Anemia · United States | 3 | Completed | Daiichi Sankyo | Mar 2007 | 145 |
How it is read
Names in the registry
- “Ferric Carboxymaltose (FCM)”, 13 entries
- “Ferric carboxymaltose”, 8 entries
- “Injectafer”, 5 entries
- “Ferric Carboxymaltose”, 5 entries
- “Ferric Carboxymaltose Injection”, 3 entries
Conditions, from the studies’ own filings
- Anemia, Iron-Deficiency, 17 studies
- Anemia, 12 studies
- Iron Deficiencies, 7 studies
- Restless Legs Syndrome, 4 studies
- Heart Failure, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.